Pharmacological prevention of diabetic cataract

Journal of Diabetes and its Complications

Volumn 18, Issue 2, 2004, Pages 129-140

  Kyselova, Z ^a   Stefek, M ^a   Bauer, V ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Diabetic cataract; Nonenzymatic glycation; Oxidative stress; Polyol pathway

Indexed keywords

2 METHYLSORBINIL; 2,4 DINITROPHENOL; ACETYLSALICYLIC ACID; ALCOHOL; ALDOSE REDUCTASE INHIBITOR; ALPHA TOCOPHEROL; AMINOGUANIDINE; ANTIOXIDANT; ASCORBIC ACID; BARBITURIC ACID DERIVATIVE; BUTYLCRESOL; CAROTENOID; CATALASE; CHOLINESTERASE INHIBITOR; DIURETIC AGENT; FLAVONOID; GLUTATHIONE PEROXIDASE; IBUPROFEN; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENOTHIAZINE; POLYOL; PYRUVIC ACID; STEROID; SUPEROXIDE DISMUTASE; THIOCTIC ACID; TRIPARANOL; TROLOX C; UNINDEXED DRUG;

CATARACT; CATARACTOGENESIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; EPIDEMIOLOGICAL DATA; EXPERIMENT; FUNCTIONAL ANATOMY; GLYCATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LABORATORY; LENS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW;

EID: 2342443119     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(03)00009-6     Document Type: Article

References (153)

1. Ajiboye R., Harding J.J. The non-enzymic glycosylation of bovine lens proteins by glucosamine and its inhibition by aspirin, ibuprofen and glutathione. Experimental Eye Research. 49:1989;31-41
2. Altomare E., Grattagliano I., Vendemaile G., Micelli-Ferrari T., Signorile A., Cardia L. Oxidative protein damage in human diabetic eye: evidence of a retinal participation. European Journal of Clinical Investigation. 27:1997;141-147
3. Ansari N.H., Bhatnagar A., Fulep E., Khanna P., Srivastava S.K. Trolox protects hyperglycaemia induced cataractogenesis in cultured rat lens. Research Communications in Chemical Pathology and Pharmacology. 84:1994;93-104
4. Ao S., Kikuchi C., Ono T. Effect of instillation of aldose reductase inhibitor FR 74366 on diabetic cataract. Investigative Ophthalmology & Visual Science. 32:1991;3078-3083
5. Araki N., Ueno N., Chakrabati B., Morino Y., Horiuchi S. Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. Journal of Biological Chemistry. 267:1992;10211-10214
6. Bantseev V., Bhardwaj R., Rathbun W., Nagasawa H., Trevithick J.R. Antioxidants and cataract: (Cataract induction in space environment and application to terrestrial ageing cataract). Biochemistry and Molecular Biology International. 42:1997;1189-1197
7. Bates C.J., Chen S., Macdonald A., Holden R. Quantitation of vitamin E and a carotenoid pigment in cataractous human lenses and the effect of a dietary supplement. International Journal for Vitamin and Nutrition Research. 66:1996;312-316
8. Baynes J.W. Role of oxidative stress in development of complication in diabetes. Diabetes. 40:1991;405-412
9. Baynes J.W., Thorpe S.R. Perspectives in diabetes: role of oxidative stress in diabetic complication - a new perspective on an old paradigm. Diabetes. 48:1999;1-9
10. Berger J., Shepard D., Morrow F., Taylor A. Relationship between dietary intake and tissue levels of reduced and total vitamin C in the guinea pig. Journal of Nutrition. 119:1989;1-7
11. Beyer-Mears A., Mistry K., Diecke F.P. Zopolrestat prevention of proteinuria and cataractogenesis in diabetes mellitus. Pharmacology. 52:1996;292-302
12. Blakytny R., Harding J.J. Prevention of cataract in diabetic rats by aspirin, paracetamol (acetaminophen) and ibuprofen. Experimental Eye Research. 54:1992;509-518
13. Borenshtein D., Ofri R., Werman M., Stark A., Tritschler H., Moeller W., Madar Z. Cataract development in diabetic sand rats treated with α-lipoic acid and its γ-linolenic acid conjugate. Diabetes/Metabolism Research and Reviews. 17:2001;44-50
14. Brown L., Rimm E.B., Seddon J.M., Giovannuci E.L., Chasan-Taber L., Spiegelman D., Willett W.C., Hankinson S.E. A prospective study of carotenoid intake and risk of cataract extraction in US men. American Journal of Clinical Nutrition. 70:1999;517-524
15. Brownlee M. Advanced glycation end products in diabetes and ageing. Annual Review of Medicine. 46:1996;223-234
16. Brownlee M., Vlassara H., Kooney A. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science. 232:1986;1629-1632
17. Bucala R., Manabe S., Urban R.C., Cerami A. Nonenzymatic modification of lens crystallins by prednisolone induces sulfhydryl oxidation and aggregate formation: in vitro and in vivo studies. Experimental Eye Research. 41:1985;353-363
18. Buchanan J.D., Armstrong D.A. The radiolysis of glyceraldehyde-3- phosphate dehydrogenase. International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine. 33:1978;409-418
19. Cameron N.E., Cotter M.A., Archibald V. Chronic N-acetyl-L-cysteine treatment prevents impaired endothelium-dependent relaxation and improves peripheral nerve blood flow and conduction in diabetic rats. European Journal of Clinical Investigation. 25:1995;A9
20. Cao X., Phillis J.W. The free radical scavenger, alpha-lipoic acid, protects against cerebral ischemia-reperfusion injury in gerbils. Free Radical Research. 23(4):1995;365-370
21. Castle L., Perkins M.J. Inhibition of chain-breaking phenolic antioxidants in SDS micelles: evidence that intermicellar diffusion rates may be rate-limiting for hydrophobic inhibitors such as alpha-tocopherol. Journal of the American Chemical Society. 108:1986;6381-6382
22. Cerami A., Crabbe J. Recent advances in ocular cataract research. TIPS Reviews. 7:1986, July;271-274
23. Chandra D., Jackson E.B., Ramana K.V., Kelley R., Srivastata S.K., Bhatnagar A. Nitric oxide prevents aldose reductase activation and sorbitol accumulation during diabetes. Diabetes. 51:2002;3095-3101
24. Chang K.C., Paek K.S., Kim H.J., Lee Y.S., Yabe-Nishimura C., Seo H.G. Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes. Molecular Pharmacology. 61:2002;1184-1191
25. Chasan-Taber L., Willett W.C., Seddon J.M., Stampfer M.J., Rosner B., Colditz G.A., Speizer F.E., Hankinson S.E. A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in US women. American Journal of Clinical Nutrition. 70:1999;509-516
26. Cheng H.M., Chylack L.T. Lens metabolism. Maisel H. Ocular lens. 1985;223-264 Dekker, New York
27. Chew E.Y., Williams G.A., Burton T.C., Barton F.B., Remaley N.A., Ferris F.L. Aspirin effects on the development of cataracts in patients with diabetes mellitus. Early treatment diabetic retinopathy study report 16. Archives of Ophthalmology. 110:1992;339-342
28. Constantino L., Rastelli G., Vianello P., Cignarella G., Barlocco D. Diabetes complications and their potential prevention: aldose reductase inhibition and other approaches. Medical Research Reviews. 19:1999;3-23
29. Cotlier E. Senile cataract: evidence for acceleration by diabetes and deceleration by salicylates. Canadian Journal of Ophthalmology. 16:1961;133-138
30. Crabbe M.J.C., Goode D. Aldose reductase: a window to the treatment of diabetic complications? Progress in Retinal Eye Research. 17:1988;313-383
31. Crompton M., Rixon K.C., Harding J.J. Aspirin prevents carbamylation of soluble lens proteins and prevents cyanate-induced phase separation opacities in vitro: a possible mechanism by which aspirin could prevent cataract. Experimental Eye Research. 40:1985;297-311
32. Dai S., McNeill J.H. Ascorbic acid supplementation prevents hyperlipidemia and improves myocardial performance in streptozotocin-diabetic rats. Diabetes Research and Clinical Practice. 27:1995;11-18
33. Devamanoharan P.S., Henein M., Ali A.H. Attenuation of sugar cataract by ethyl pyruvate. Molecular and Cellular Biochemistry. 200:1999;103-109
34. Dixit B.L., Ramana K.V., Chandra D., Jackson E.B., Srivastata S., Bhatnagar A., Srivastata S.K. Metabolic regulation of aldose reductase activity by nitric oxide donors. Chemico-Biological Interactions. 130-132:2001;573-581
35. Duhaiman A.S. Glycation of human lens proteins from diabetic and (nondiabetic) senile cataract patients. Glycoconjugate Journal. 12:1995;618-621
36. Fu M.X., Wells-Knecht K.J., Blackledge J.A., Lyons T.J., Thorpe S.R., Baynes J.W. Glycation, glycoxidation, and cross-linking of collagen by glucose-kinetics, mechanism and inhibition of late stages of the Maillard reaction. Diabetes. 43:1994;676-683
37. Ganea E., Harding J.J. Molecular chaperones protect against glycation-induced inactivation of glucose 6-phosphate dehydrogenase. European Journal of Biochemistry. 231:1995;181-185
38. Garland D. Role of specific metal-catalyzed oxidation in lens aging and cataract: a hypothesis. Experimental Eye Research. 50:1990;677-682
39. Gervasi G.B., Bartoli C., Catalani R. Effects of a new aldose reductase inhibitor on diabetic complications in rats. Arzneimittel-Forschung. 41:1991;1160-1163
40. Girao H., Mota C., Pereira P. Cholesterol may act as an antioxidant in lens membranes. Current Eye Research. 18(6):1999;448-454
41. Giugliano D., Ceriello A., Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 19:1996;257-267
42. Gonzalez A.-M., Sohor M., McLean P. The effect of an aldose reductase inhibitor (sorbinil) on the level of metabolites in lenses of diabetic rats. Diabetes. 32:1983;482-485
43. Gupta P.P., Pandey D.N., Pandey D.J., Sharma A.L., Srivastava R.K., Mishra S.S. Aspirin in experimental cataractogenesis. Indian Journal of Medical Research. 80:1984;703-707
44. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine. 2nd ed. 1989;Clarendon Press, Oxford
45. ε-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients. Diabetes Care. 23:2000;1539-1545
46. Hankinson S.E., Stampfer M.J., Seddon J.M., Colditz G.A., Rosner B., Speizer F.E., Willett W.C. Nutrient intake and cataract extraction in women: a prospective study. BMJ. 305:1992;335-339
47. Harding J., van Heyningen R. Drugs including alcohol that act as risk factors for cataract, and possible protection against cataract by aspirin-like analgesics and cyclopenthiazide. British Journal of Ophthalmology. 72:1988;809-814
48. Harding J.J. Can drugs or micronutrients prevent cataract? Drugs & Aging. 18(7):2001;473-486
49. Harding J.J., Egerton M., Harding R.S. Protection against cataract by aspirin, paracetamol and ibuprofen. Acta Ophthalmologica. 67:1989;518-524
50. Hotta N., Kakuta H., Ando F., Sakamoto N. Current progress in clinical trials of aldose reductase inhibitors in Japan. Experimental Eye Research. 50:1990;625-628
51. Huby R., Harding J.J. Non-enzymic glycosylation (glycation) of lens proteins by galactose and protection by aspirin and reduced glutathione. Experimental Eye Research. 47:1988;53-59
52. Jacob R.F., Cenedella R.J., Mason R.P. Direct evidence for immiscible cholesterol domains in human ocular lens fiber cell plasma membranes. Journal of Biological Chemistry. 274(44):1999;31613-31618
53. Jacob S., Streeper R.S., Fogt D.L. The antioxidant α-lipoic acid enhances insulin stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes. 45:1996;1024-1029
54. Jacques P.F., Chylack L.T., Hankinson S.E., Khu P.M., Rogers G., Friend J., Tung W., Wolfe J.K., Padhye A., Willett W.C., Taylor A. Long-term nutrient intake and early age-related nuclear lens opacities. Archives of Ophthalmology. 119:2001;1009-1019
55. Jacques P.F., Chylack L.T. Jr. Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. American Journal of Clinical Nutrition. 53:1991;352S-355S
56. Jacques P.F., Lahav M., Willett W.C., Taylor A. Relationship between long-term vitamin C intake and prevalence of cataract and macular degeneration. Experimental Eye Research. 55(Suppl. 1):1992;S152
57. Jacques P.F., Taylor A. Micronutrients and age-related cataracts. Bendich A., Butterworth C.E. Micronutrients in health and in disease prevention. 1991;359-379 Dekker, New York
58. Jacques P.F., Taylor A., Hankinson S.E., Willett W.C., Mahnken B., Lee Y., Vaid K., Lahav M. Long-term vitamin C supplement use and prevalence of age-related lens opacities. American Journal of Clinical Nutrition. 66:1997;911-916
59. Kador P.F., Inoue J., Secchi E.F. Effects of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats. Experimental Eye Research. 67:1998;203-208
60. Kador P.F., Lee J.W., Fujisawa S., Blessing K., Lou M.F. Relative importance of aldose reductase versus nonenzymatic glycosylation sugar cataract formation in diabetic rats. Journal of Ocular Pharmacology and Therapeutics. 16(2):2000;149-160
61. Khatami M., Suldan Z., David I. Inhibitory effects of pyridoxal phosphate, ascorbate and aminoguanidine on non-enzymic glycosylation. Life Science. 43:1988;1725-1731
62. Kilic F., Bhardwaj R., Trevithick J.R. Modelling cortical cataractogenesis: XVIII. In vitro diabetic cataract reduction by venoruton. A flavonoid which prevents lens opacification. Acta Ophthalmologica Scandinavica. 74:1996;372-378
63. Kilic F., Handelman G.J., Serbinova E., Packer L., Trevithick J.R. Modelling cortical cataractogenesis 17: in vitro effect of α-lipoic acid on glucose-induced lens membrane damage, a model of diabetic cataractogenesis. Biochemistry and Molecular Biology International. 37:1995;361-367
64. Kinoshita J.H. A thirty year journey in the polyol pathway. Experimental Eye Research. 50:1990;567-573
65. Kinoshita J.H., Kador P., Catiles M. Aldose reductase in diabetic cataracts. JAMA, The Journal of American Medical Association. 246(3):1981;257-261
66. Kinoshita J.H., Nishimura C. The involvement of aldose reductase in diabetic complications. Diabetes and Metabolism Reviews. 4(4):1988;323-337
67. Klip A., Volchuk A., Ramlal T., Ackerley C., Mitsumoto Y. Glucose transporters of muscle cells in culture: development regulation and modulation by lipoic acid, an anti-hyperglycemic agent. Draznin B., LeRoith D. Molecular biology of diabetes. Part II. 1994;511-528 Humana Press, Totowa
68. Knekt P., Heliovaara M., Rissanen A., Aromaa A., Aaran R. Serum antioxidant vitamins and risk of cataract. BMJ. 305:1992;1392-1394
69. Kowluru R.A., Kennedy A. Therapeutic potential of antioxidants and diabetic retinopathy. Expert Opinion on Investigational Drugs. 10(9):2001;1665-1676
70. Kowluru R.A., Kern T.S., Engerman R.L. Abnormalities of retinal metabolism in diabetes or experimental galactosemia: IV. Antioxidant defense system. Free Radical Biology and Medicine. 22:1996;587-592
71. Koya D., King G.L. Protein kinase C activation and the development of diabetic complications. Diabetes. 47:1998;859-866
72. Kupfer C. The conquest of cataract: a global challenge. Transactions of the Ophthalmological Societies of the United Kingdom. 104:1984;1-10
73. Lee A.Y.W., Chung S.S.M. Contribution of polyol pathway to oxidative stress in diabetic cataract. FASEB Journal. 13:1999;23-30
74. Lee K.-W., Mossine V., Ortwerth B.J. The relative ability of glucose and ascorbate to glycate and cross-link lens proteins in vitro. Experimental Eye Research. 67:1998;95-104
75. Leske M.C., Chylack L.T., He Q., Wu S.Y., Schoenfeld E., Friend J., Wolfe J. Antioxidants vitamins and nuclear opacities: the longitudinal study of cataract. Ophthalmology. 105:1998;831-836
76. Leske M.C., Chylack L.T. Jr., Wu S. The lens opacities case-control study: the lens opacities case-control study: risk factors for cataract. Archives of Ophthalmology. 109:1991;244-251
77. Leske M.C., Wu S.Y., Hyman L., Sperduto R., Underwood B., Chylack L.T., Milton R.C., Srivastava S., Ansari N. The Lens Opacities Case-Control Study Group Biochemical factors in the lens opacities. Case-control study. Archives of Ophthalmology. 113:1995;1113-1119
78. Lewis B.S., Harding J.J. The effects of aminoguanidine on the glycation (non-enzymic glycosylation) of lens proteins. Experimental Eye Research. 50:1990;463-467
79. Lin P.P., Barry R.C., Smith D.J., Smith J.B. In vivo acetylation identified at lysine 70 of human lens αA-crystallins. Protein Science. 7:1998;1451-1457
80. Linklater H.A., Dzialoszynski T., McLeod H.L., Trevithick J.R. Modelling cortical cataractogenesis: VIII. Effects of butylated hydroxytoluene (BHT) in reducing protein leakage from lenses in diabetic rats. Experimental Eye Research. 43:1986;305-314
81. Lyle B.J., Mares-Perlman J.A., Klein B.E., Klein R., Greger J.L. Antioxidants intake and risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study. American Journal of Epidemiology. 149:1999;801-809
82. Lyle B.J., Mares-Perlman J.A., Klein B.E., Klein R., Palta M., Bowen P.E., Greger J.L. Serum carotenoids and tocopherols and incidence of age-related nuclear cataract. American Journal of Clinical Nutrition. 69:1999;272-277
83. Lyons T.J., Silvestri G., Dunn J.A., Dyer D.G., Baynes J.W. Role of glycation in modification of lens crystallins in diabetic and nondiabetic senile cataracts. Diabetes. 40:1991;1010-1015
84. Maitra I., Serbinova E., Trischler H., Packer L. α-Lipoic acid prevents buthionine sulfoximine-induced cataract formation in newborn rats. Free Radical Biology & Medicine. 18:1995;823-829
85. Mares-Perlman J.A., Brady W.E., Klein B.E., Klein R., Haus G.J., Palta M., Ritter L.L., Shoff S.M. Diet and nuclear lens opacities. American Journal of Epidemiology. 141:1995;322-334
86. Mares-Perlman J.A., Klein B.E.K., Klein R., Ritter L.L. Relationship between lens opacities and vitamin and mineral supplement use. Ophthalmology. 101:1994;315-325
87. Marin P., Maus M., Bockaert J., Glowinski J., Premont J. Oxygen free radicals enhance the nitric oxide-induced covale NAD(+)-linkage to neuronal glyceraldehyde-3-phosphate dehydrogenase. Biochemical Journal. 309:1995;891-898
88. Mario U.D., Pugliese G. 15th Golgi lecture: from hyperglycaemia to the dysregulation of vascular remodelling in diabetes. Diabetologia. 44:2001;674-692
89. Minassian D.C., Reidy A., Desai P., Farrow S., Vafidis G., Minassian A. The deficit in cataract surgery in England and Wales and the escalating problem of visual impairment: epidemiological modeling of the population dynamics of cataract. British Journal of Ophthalmology. 84:2000;4-8
90. Mohan M., Sperduto R.D., Angra S.K., Milton R.C., Mathur R.L., Underwood B.A., Jaffery A., Pandya C.B., Chhabra V.K., Vajpayee R.B. India-US case control study of age-related cataracts. India-US case control study group. Archives of Ophthalmology. 107:1989;670-676
91. Monnier V.M., Sell D.R., Nagaraj R.H., Miyata S., Grandhee S., Odetti P., Ibrahim S.A. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes. 41:1992;36-41
92. Nagaraj R.H., Sell D., Prabhakaram M., Ortwerth B.J., Monnier V.M. High correlation between pentosidine protein crosslinks and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis. Proceedings of the National Academy of Science of the United States of America. 88:1991;10257-10261
93. Natraj C.V., Gandhi V.M., Menon K.K.G. Lipoic acid and diabetes: effect of dihydrolipoic acid administration in diabetic rats and rabbits. Journal of Bioscience. 6:1984;37-46
94. Nishikawa T., Edelstein D., Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney International. 58(77):2000;S26-S30
95. Nishikawa T., Edelstein D., Du X.-L. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature. 404:2000;787-790
96. Obrosova I., Gao X., Greene D.A., Stevens M.J. Diabetes-induced changes in lens antioxidant status, glucose utilization and energy metabolism: effect of DL-α-lipoic acid. Diabetologia. 41:1998;1442-1450
97. Ohta Y., Okada H., Majima Y., Ishiguro I. Anticataract action of vitamin E: its estimation using an in vitro steroid cataract model. Ophthalmic Research. 28(2):1996;16-25
98. Ohta Y., Yamasaki T., Goto H., Majima Y., Ishiguro I. Cataract development in 12-month-old rats fed a 25% galactose diet and its relation to osmotic stress and oxidative damage. Ophthalmic Research. 31:1999;321-331
99. Ohta Y., Yamasaki T., Niwa T., Majima Y. Preventive effect of vitamin E-containing liposome instillation on cataract in 12-month-old rats fed a 25% galactose diet. Journal of Ocular Pharmacology and Therapeutics. 16(4):2000;323-335
100. Ortwerth B.J., Feather M.S., Olesen P.R. The precipitation and cross-linking of lens crystallins by ascorbic acid. Experimental Eye Research. 47:1988;155-168
101. Ou P., Nourooz-Zadeh J., Tritschler H.J., Wolff S. Activation of aldose reductase in rat lens and metal-ion chelation by aldose reductase inhibitors and lipoic acid. Free Radical Research. 25(4):1996;337-346
102. Packer L. α-Lipoic acid: a metabolic antioxidant which regulates NF-κB signal transduction and protects against oxidative injury. Drug Metabolism Reviews. 30:1998;245-275
103. Pugliese G., Tilton R.G., Williamson J.R. Glucose-induced metabolic imbalances in the pathogenesis of diabetic vascular disease. Diabetes and Metabolism Reviews. 7:1991;35-39
104. Qin W., Smith J.B., Smith D.L. Reaction of aspirin with cysteinyl residues of lens γ-crystallins: a mechanism for the proposed anti-cataract effect of aspirin. Biochimica Biophysica Acta. 1181:1993;103-110
105. Rao G.N., Cotlier E. Aspirin prevents the nonenzymic glycosylation and carbamylation of the human eye crystallins in vitro. Biochemical and Biophysical Research Communications. 151:1988;991-996
106. Reddy V.N., Giblin F.J., Lin L.-R., Chakrapani B. The effect of aqueous humor ascorbate on ultraviolet-B-induced DNA damage in lens epithelium. Investigative Ophthalmology & Visual Science. 39:1998;344-350
107. Rivera-Nieves J., Thompson W.C., Levine R.L., Moss J. Thiols mediate superoxide-dependent NADH modification of glyceraldehyde-3-phosphate dehydrogenase. Journal of Biological Chemistry. 274:1999;19525-19531
108. Robertson J.Mc.D., Donner A.P., Trevithick J.R. Vitamin C intake and risk for cataracts in humans. Annals of the New York Academy of Sciences. 570:1989;372-382
109. Robison W.G., Houlder N., Kinoshita J.H. The role of lens epithelium in sugar cataract formation. Experimental Eye Research. 50:1990;641-646
110. Rouhiainen P., Rouhiainen H., Salonen J.T. Association between low plasma vitamin E concentration and progression of early cortical lens opacities. American Journal of Epidemiology. 144:1996;496-500
111. Salvemini D., Cuzzocrea S. Superoxide, superoxide dismutase and ischemic injury. Current Opinion in Investigational Drugs. 3:2002;886-895
112. Sanderson J., McLauchlan W.R., Williamson G. Can carotenoids reduce oxidation-induced cataract? Biochemical Society Transactions. 24:1996;385S
113. Sanderson J., McLauchlan W.R., Williamson G. Quercetin inhibits hydrogen peroxide-induced oxidation of the rat lens. Free Radical Biology & Medicine. 26:1999;639-645
114. Sarma U., Brunner E., Evans J., Wormald R. Nutrition and the epidemiology of cataract and age-related maculopathy. European Journal of Clinical Nutrition. 48:1994;1-8
115. Sato S., Mori K., Wyman M., Kador P.F. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175. Experimental Eye Research. 66:1998;217-222
116. Saxena P., Saxena A.K., Monnier V.M. High galactose levels in vitro and in vivo impair ascorbate regeneration and increase ascorbate-mediated glycation in cultured rat lens. Experimental Eye Research. 63:1996;535-545
117. Schinzel R., Münch G., Heidland A., Sebekova K. Advanced glycation end products in end-stage renal disease and their removal. Nephron. 87:2001;295-303
118. Schleicher E.D., Weigert C. Role of the hexosamine biosynthetic pathway in diabetic nephropathy. Kidney International. 58:2000;S13-S18
119. Scott B.C., Aruoma O.I., Evans P.J. Lipoic acid and dihydrolipoic acid as antioxidants. A critical evaluation. Free Radical Research. 20:1994;119-133
120. Seo H.G., Nishinaka T., Yabe-Nishimura C. Nitric oxide up-regulates aldose reductase expression in rat vascular smooth muscle cells: a potential role for aldose reductase in vascular remodeling. Molecular Pharmacology. 57:2000;709-717
121. Shamsi F.A., Sharkey E., Creighton D., Nagaraj R.H. Maillard reactions in lens proteins: methylglyoxal-mediated modifications in the rat lens. Experimental Eye Research. 70:2000;369-380
122. Spector A. Review: oxidative stress and diseases. Journal of Ocular Pharmacology and Therapeutics. 16(2):2000;193-201
123. 2. Investigative Ophthalmology & Visual Science. 39:1998;1188-1197
124. Spycher S.E., Tabataba-Vakii S., O'Donnell V.B., Palomba L., Azzi A. Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells. FASEB Journal. 11:1997;181-188
125. Srivastava S.K., Ansari N.H. Prevention of sugar-induced cataractogenesis in rats by butylated hydroxytoluene. Diabetes. 37:1988;1505-1508
126. Stribling D. Clinical trials with aldose reductase inhibitors. Experimental Eye Research. 50:1990;621-624
127. Suzuki Y.J., Tschiya M., Packer L. Lipoate prevents glucose-induced protein modifications. Free Radical Research Communications. 17:1992;211-217
128. Swamy M.S., Abraham E.C. Inhibition of lens crystallins glycation and high molecular weight aggregate formation by aspirin in vitro and in vivo. Investigative Ophthalmology & Visual Science. 30:1989;1120-1126
129. Swamy M.S., Green K., Abraham E.C. Inhibition of cataracts in moderately diabetic rats by aminoguanidine. Experimental Eye Research. 62(5):1996;505-510
130. Tavani A., Negri E., La Vecchia C. Food and nutrient intake and risk of cataract. Annals of Epidemiology. 6:1996;41-46
131. Taylor A., Jacques P.F., Nadler D., Morrow F., Sulsky S.I., Shepard D. Relationship in humans between ascorbic acid consumption and levels of total and reduced ascorbic acid in lens, aqueous humour, and plasma. Current Eye Research. 10:1991;751-759
132. Taylor A., Nowell T. Oxidative stress and antioxidant function in relation to risk for cataract. Advances in Pharmacology. 38:1997;515-536
133. Teikari J.M., Rautalahti M., Haukka J., Jarvinen P., Hartman A.M., Virtamo J., Albanes D., Heinonen O. Incidence of cataract operations in Finish male smokers unaffected by alpha tocopherol or beta carotene supplements. Journal of Epidemiology and Community Health. 52:1998;468-472
134. The Italian-American Cataract Study Group Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. American Journal of Epidemiology. 133:1991;541-553
135. Thornalley P.J. Pharmacology of methylglyoxal. General Pharmacology. 27:1996;565-573
136. van der Pols J.C. A possible role for vitamin C in age-related cataract. Proceedings of the Nutrition Society. 58:1999;295-301
137. van Heyningen R., Harding J.J. Do aspirin-like analgesics protect against cataract? A case control study. Lancet. 1:1986;1111-1113
138. VanMarle J., Vrensen G.F. Cholesterol content of focal opacities and multilamellar bodies in the human lens: filipin cytochemistry and freeze fracture. Ophthalmic Research. 32(6):2000;285-291
139. Varma S.D. Scientific basis for medical therapy of cataracts by antioxidants. American Journal of Clinical Nutrition. 53(1):1991;335-345
140. Varma S.D., Chand D., Sharma Y.R., Kuck J.F., Richards R.D. Oxidative stress on lens and cataract formation: role of light and oxygen. Current Eye Research. 3:1984;35-57
141. Varma S.D., Kinoshita J.H. Sorbitol pathway in diabetic and galactosemic rat lens. Biochimica Biophysica Acta. 338:1990;632-640
142. Varma S.D., Ramachandran S., Devamanoharan P.S., Morris S.M., Ali A.H. Prevention of oxidative damage to rat lens by pyruvate in vitro: possible attenuation in vivo. Current Eye Research. 14:1995;643-649
143. Vitale S., West S., Hallfrisch J., Alston C., Wang F., Moorman C., Muller D., Singh V., Taylor H.R. Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology. 4:1993;195-203
144. Wagh S.S., Natraj C.V., Menon K.K.G. Mode of action of lipoic acid in diabetes. Journal of Bioscience. 11:1987;59-74
145. Westwood M.E., Thornalley P.J. Glycation and advanced glycation end products. Colacao C. The glycation hypothesis of atherosclerosis. 1997;59-87 Landes Bioscience, Georgetown, TX
146. Williamson J.R., Chang K., Frangos M., Hasan K.S., Ido Y., Kawamura T., Nyengaard J.R., van den Enden M., Kilo C., Tilton R.G. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 42:1993;801-813
147. Wohaieb S.A., Godin D.V. Alterations in free radical tissue - defense mechanisms in streptozotocin-induced diabetes. Diabetes. 36:1987;1014-1018
148. Wu T.W., Hashimoto A., Au J.X., Wu J., Mickle D.A.G., Carey D. Trolox protects rat hepatocytes against oxyradical damage and the ischemic rat liver from reperfusion injury. Hepatology. 13:1989;575-580
149. Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacological Reviews. 50:1998;21-33
150. Yeum K.-J., Taylor A., Tang G., Russell R.M. Measurement of carotenoids, retinoids, and tocopherols in human lenses. Investigative Ophthalmology & Visual Science. 36:1995;2756-2761
151. Young R.W. Age-related cataract. 1991;Oxford University Press, New York
152. Zhao W., Devamanoharan P.S., Varma S.D. Fructose induced deactivation of glucose 6-phosphate dehydrogenase activity and its prevention by pyruvate: implications in cataract prevention. Free Radical Research. 29:1998;315-320
153. Zhao W., Devamanoharan P.S., Varma S.D. Fructose mediated damage to lens alpha-crystalline: prevention by pyruvate. Biochimica Biophysica Acta. 1500:2000;161-168